Qihan Biotech

Advertisement

cGxPJobs Banner

Qihan Biotech’s QT-019B Earns FDA RMAT and Breakthrough Therapy Designations

HANGZHOU, China, June 11, 2026 Qihan Biotech announced that its investigational universal dual-target CAR-T therapy QT-019B has received both...

By cGxPwire Editor
June 17, 2026

Read More

Advertisement

cGxPJobs

Directory